Oscar Health financials
$29.77+0.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $11.50B | $8.99B | $5.71B | $3.94B | $1.84B |
| Gross profit | $1.48B | $1.66B | $1.07B | $655.2M | $212.4M |
| Gross margin | 12.9% | 18.5% | 18.7% | 16.6% | 11.6% |
| Operating income | -$599.3M | -$128.5M | -$391.1M | -$617.5M | -$602.1M |
| Net income | -$443.2M | $25.4M | -$270.7M | -$606.3M | -$572.6M |
| Net margin | −3.9% | 0.3% | −4.7% | −15.4% | −31.2% |
| Diluted EPS | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| EBITDA | -$570.4M | -$96.3M | -$360.4M | -$602.2M | -$448.4M |
| Operating cash flow | $1.09B | $978.2M | -$272.2M | $380.3M | -$181.7M |
| Free cash flow | $1.06B | $950.3M | -$297.7M | $351.3M | -$207.6M |
| Diluted shares | 262.4M | 265.9M | 221.7M | 212.5M | 179.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B |
| Short-term investments | $1.22B | $624.5M | $689.8M | $1.40B | $587.1M |
| Total debt | $430.1M | $299.6M | $298.8M | $298.0M | $0.00 |
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B |
| Shareholders' equity | $980.7M | $1.02B | $806.1M | $892.4M | $1.39B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology